Correction: T cell activation and differentiation is modulated by a CD6 domain 1 antibody Itolizumab.

Bughani, Usha; Saha, Arindam; Kuriakose, Anshu; Nair, Reshmi; Sadashivarao, Ravindra B; Venkataraman, Rasika; Patel, Swati; Tushar Deshchougule, Anuja et al. · PLoS One · 2018

Where this comes from

Record sourced from PubMed, PMID 29381749.
Also identified by DOI 10.1371/journal.pone.0192335 and PMC identifier 5790287.
No licence information is recorded for this record.
Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0180088.].

Read the full text

View on PubMed · Publisher (DOI)